Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001628280-24-038196
Filing Date
2024-08-22
Accepted
2024-08-22 15:00:58
Documents
1
Period of Report
2024-08-19

Document Format Files

Seq Description Document Type Size
1 FORM 4 wk-form4_1724353252.html 4  
1 FORM 4 wk-form4_1724353252.xml 4 3453
  Complete submission text file 0001628280-24-038196.txt   4935
Mailing Address 3515 LYMAN BOULEVARD CHASKA MN 55318
Business Address 3515 LYMAN BOULEVARD CHASKA MN 55318 9523684300
LIFECORE BIOMEDICAL, INC. \DE\ (Issuer) CIK: 0001005286 (see all company filings)

EIN.: 943025618 | State of Incorp.: DE | Fiscal Year End: 0526
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address 3515 LYMAN BLVD. CHASKA MN 55318
Business Address
Johnson Paul Harold (Reporting) CIK: 0002034858 (see all company filings)

Type: 4 | Act: 34 | File No.: 000-27446 | Film No.: 241231649